Gregory MacMichael

Gregory MacMichael

Keine laufenden Positionen mehr
70 Jahre
Health Technology
Consumer Services

Profil

Gregory MacMichael is the founder of CMC BioServices LLC, which was founded in 2010.
He held former positions as Vice President at Wyeth LLC, Global Head-Biologics Development at Novartis AG, Senior Vice President-Process Development at Rocket Pharmaceuticals, Inc., Senior Vice President-Development & Manufacturing at NantKwest, Inc. from 2017 to 2018, and Senior Vice President-Technical Operations at Sio Gene Therapies, Inc. from 2018 to 2019.
He was also the Chief Technology Officer at Castle Creek Biosciences, Inc. from 2020 to 2021 and Chief Technical Officer at Coya Therapeutics, Inc. He received a doctorate from Mississippi State University, a graduate and doctorate degree from North Carolina State University, and an undergraduate degree from The Pennsylvania State University.

Ehemalige bekannte Positionen von Gregory MacMichael

UnternehmenPositionEnde
SIO GENE THERAPIES INC. Corporate Officer/Principal 01.07.2019
IMMUNITYBIO, INC. Corporate Officer/Principal 01.09.2018
ROCKET PHARMACEUTICALS, INC. Corporate Officer/Principal 01.12.2016
COYA THERAPEUTICS, INC. Technik-/Wissenschafts-/F&E-Leiter -
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Gregory MacMichael im Detail an

Ausbildung von Gregory MacMichael

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

7

Beziehungen ersten Grades

11

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

CMC BioServices LLC

  1. Börse
  2. Insiders
  3. Gregory MacMichael
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT